(-)-Indolmycin
(-)-Indolmycin Basic information
- Product Name:
- (-)-Indolmycin
- Synonyms:
-
- (S)-5-[(1R)-1-(1H-Indol-3-yl)ethyl]-2-(methylamino)-4(5H)-oxazolone
- [5S,(-)]-5-[(R)-1-(1H-Indol-3-yl)ethyl]-2-methylamino-2-oxazolin-4-one
- Pa-155-A
- (-)-INDOLMYCIN
- 4(5H)-Oxazolone, 5-[(1R)-1-(1H-indol-3-yl)ethyl]-2-(methylamino)-, (5S)-
- indolomycin
- CAS:
- 21200-24-8
- MF:
- C14H15N3O2
- MW:
- 257.29
- Mol File:
- 21200-24-8.mol
(-)-Indolmycin Chemical Properties
- Melting point:
- 209-210°
- alpha
- D25 -214° (c = 2 in methanol)
- Boiling point:
- 420.8±37.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C, protect from light
- solubility
- Soluble in ethanol;methanol;DMSO;dimethyl formamide
- form
- powder
- pka
- 16.65±0.30(Predicted)
- color
- white
(-)-Indolmycin Usage And Synthesis
Uses
Indolmycin is a highly selective antibiotic which acts as a tryptophan anti-metabolite. Recent research has shown that indolmycin is active against Mycobacteria and H. pylori, and can stimulate transcription in Escherichia coli.
Uses
Indolmycin is an antibiotic that inhibits bacterial tryptophanyl-tRNA synthetase.
Definition
ChEBI: A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by methylamino and [(1R)-1-(1H-indol-3-yl)ethyl] gro ps, respectively.
Biological Activity
indolmycin is an antibiotic.tryptophanyl-trna synthetase (trprs) catalyzes activation of tryptophan through atp and transfer to trnatrp , leading to translation of the genetic code for tryptophan.
in vitro
indolmycin was found to ba a bacteriostatic that showed good activity against methicillin-resistant s. aureus, methicillin-susceptible staphylococcus aureus, and vancomycin-intermediate s. aureus, including strains resistant to mupirocin or fusidic acid. spontaneous indolmycin-resistant mutants was observed at a lower frequency than those selected by mupirocin or fusidic acid and exhibited no cross-resistance with the comparative drugs. high-level resistance of indolmycin at its mic of 128 mg/l that was associated with an h43n mutation in tryptophanyl-trna synthetase, the target enzyme of indolmycin, led to loss of bacterial fitness. however, the locus responsible for low-level indolmycin resistance (indolmycin mics 8-32 mg/l) was not identified [1].
in vivo
animal study found that indolmycin could completely clear h. pylori in experimentally infected mongolian gerbils at a dose of 10 mg/kg. therefore, indolmycin could be regarded as a candidate for the treatment of h. pylori infection [2].
IC 50
30 μm for prokaryotic tryptophanyl-trna synthetase
References
[1] hurdle jg, o'neill aj, chopra i. anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections. j antimicrob chemother. 2004 aug;54(2):549-52. epub 2004 jul 8.
[2] vecchione jj, sello jk. a novel tryptophanyl-trna synthetase gene confers high-level resistance to indolmycin. antimicrob agents chemother 2009; 53: 3972-3980.
(-)-IndolmycinSupplier
- Tel
- 400-6206333 18021050169
- market@aladdin-e.com
- Tel
- 18149758185 18149758185
- sales-cpd@caerulumpharma.com
- Tel
- 1-516-6625404
- support@alfa-chemistry.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 010-60605840 18892239720
- psaitong@jm-bio.com